ArticleMolecular and clinical oncology2021

Prevalence and profiles of ramucirumab-associated severe ascites in patients with hepatocellular carcinoma.

Naoki Kamachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.